Digol, Laurencia S.
HRN: 23-30-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/22/2023
07/28/2023
IV
2.25
Q6
Sepsis Sec To CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes